In rare cases, stroke-like symptoms, such as tingling in the face and the left arm, can occur during an acute…
Articles by Patricia Inácio, PhD
Newbury Pharmaceuticals is launching its injectable therapy of icatibant, the active agent of Firazyr, in Sweden and Norway…
Orladeyo (berotralstat), an approved therapy for preventing swelling attacks in hereditary angiodema (HAE), was effective at controlling attacks…
Short-term treatment with Berinert, a plasma-derived form of the C1 inhibitor protein, successfully prevented acute swelling attacks in a…
Spanish patients with hereditary angioedema reported fewer severe attacks and longer delays for treatment with Firazyr (icatibant injection)…
Favipiravir, an antiviral medication used to treat influenza and, more recently, COVID-19, may trigger angioedema in some individuals, a…
The burden that hereditary angioedema (HAE) has on patients’ quality of life is seldom discussed during clinical visits, a…
A new mutation in the SERPING1 gene linked to hereditary angioedema (HAE) type 1 was identified in three of five members…
Swelling attacks affecting the airway usually occur in hereditary angioedema patients between the ages of 20 and 30 —…
Switching from under-the-skin injections to oral pills of Orladeyo (berotralstat), a preventive treatment, can be done without the need…